Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual methadone for cancer-related breakthrough pain
NCT00351637Phase 2Terminated
- Sponsor
- Alberta Health Services
- Start
- Dec 2006
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methadone in cancer pain, breakthrough pain, sponsored by Alberta Health Services. Started Dec 2006; status: terminated.
02
Drugs
methadone
03
Conditions
cancer painbreakthrough pain
Beyond the preview
Go deeper on NCT00351637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351637.